Current status of the human malformation map

Area of Science:

• Genetics
• Molecular Biology
• Medical Genetics

Background:

• Recombinant DNA technology is increasingly used for gene mapping and cloning in dysmorphic syndromes.
• Significant progress has been made, with genes for nearly 40% of syndromes in Smith's Recognizable Patterns of Human Malformation identified.
• This technological advancement is transforming the understanding of genetic disorder mechanisms among clinical geneticists.

Purpose of the Study:

• To leverage positional cloning for understanding the fundamental pathogenesis of human diseases, particularly malformation syndromes.
• To highlight the crucial role of mouse models in advancing human molecular biology.
• To emphasize the indispensable contribution of clinicians in documenting observations vital for gene mapping.

Main Methods:

• Application of recombinant DNA technology for gene mapping and identification.
• Utilizing positional cloning strategies to isolate disease-associated genes.
• Integrating knowledge from mouse models and clinical observations for gene discovery.

Main Results:

• Genes responsible for a substantial proportion (nearly 40%) of malformation and dysplasia syndromes have been mapped and/or identified.
• Successful gene cloning in dysmorphic syndromes has often been facilitated by identifying patients with chromosomal rearrangements.
• The collaborative efforts between molecular biologists and clinical geneticists are proving effective.

Conclusions:

• Positional cloning is a powerful tool for elucidating the pathogenesis of genetic disorders.
• Clinical observations and mouse models are essential complements to molecular techniques in gene discovery.
• Continued collaboration between disciplines will accelerate the identification of genes underlying numerous other disorders.